United States Specialty Pharmaceutical Market Report 2017




In this report, the United States Specialty Pharmaceutical market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report splits the United States market into seven regions: The West Southwest The Middle Atlantic New England The South The Midwest with sales (volume), revenue (value), market share and growth rate of Specialty Pharmaceutical in these regions, from 2012 to 2022 (forecast). United States Specialty Pharmaceutical market competition by top manufacturers/players, with Specialty Pharmaceutical sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including Pfizer Roche Amgen AbbVie Novo Nordisk Johnson & Johnson Sanofi-Aventis Merck Eli Lilly Novartis 3sbio Changchun High Tech CP Guojian Pharmacy Biotech Pharma Gelgen Biopharma Innovent On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into Antibody Hormone Growth Factors Other On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate of Specialty Pharmaceutical for each application, including Tumor Diabetes Cardiovascular Hemophilia Other If you have any special requirements, please let us know and we will offer you the report as you want.


Table of Contents

United States Specialty Pharmaceutical Market Report 2017
1 Specialty Pharmaceutical Overview
    1.1 Product Overview and Scope of Specialty Pharmaceutical
    1.2 Classification of Specialty Pharmaceutical by Product Category
        1.2.1 United States Specialty Pharmaceutical Market Size (Sales Volume) Comparison by Type (2012-2022)
        1.2.2 United States Specialty Pharmaceutical Market Size (Sales Volume) Market Share by Type (Product Category) in 2016
        1.2.3 Antibody
        1.2.4 Hormone
        1.2.5 Growth Factors
        1.2.6 Other
    1.3 United States Specialty Pharmaceutical Market by Application/End Users
        1.3.1 United States Specialty Pharmaceutical Market Size (Consumption) and Market Share Comparison by Application (2012-2022)
        1.3.2 Tumor
        1.3.3 Diabetes
        1.3.4 Cardiovascular
        1.3.5 Hemophilia
        1.3.6 Other
    1.4 United States Specialty Pharmaceutical Market by Region
        1.4.1 United States Specialty Pharmaceutical Market Size (Value) Comparison by Region (2012-2022)
        1.4.2 The West Specialty Pharmaceutical Status and Prospect (2012-2022)
        1.4.3 Southwest Specialty Pharmaceutical Status and Prospect (2012-2022)
        1.4.4 The Middle Atlantic Specialty Pharmaceutical Status and Prospect (2012-2022)
        1.4.5 New England Specialty Pharmaceutical Status and Prospect (2012-2022)
        1.4.6 The South Specialty Pharmaceutical Status and Prospect (2012-2022)
        1.4.7 The Midwest Specialty Pharmaceutical Status and Prospect (2012-2022)
    1.5 United States Market Size (Value and Volume) of Specialty Pharmaceutical (2012-2022)
        1.5.1 United States Specialty Pharmaceutical Sales and Growth Rate (2012-2022)
        1.5.2 United States Specialty Pharmaceutical Revenue and Growth Rate (2012-2022)

2 United States Specialty Pharmaceutical Market Competition by Players/Suppliers
    2.1 United States Specialty Pharmaceutical Sales and Market Share of Key Players/Suppliers (2012-2017)
    2.2 United States Specialty Pharmaceutical Revenue and Share by Players/Suppliers (2012-2017)
    2.3 United States Specialty Pharmaceutical Average Price by Players/Suppliers (2012-2017)
    2.4 United States Specialty Pharmaceutical Market Competitive Situation and Trends
        2.4.1 United States Specialty Pharmaceutical Market Concentration Rate
        2.4.2 United States Specialty Pharmaceutical Market Share of Top 3 and Top 5 Players/Suppliers
        2.4.3 Mergers & Acquisitions, Expansion in United States Market
    2.5 United States Players/Suppliers Specialty Pharmaceutical Manufacturing Base Distribution, Sales Area, Product Type

3 United States Specialty Pharmaceutical Sales (Volume) and Revenue (Value) by Region (2012-2017)
    3.1 United States Specialty Pharmaceutical Sales and Market Share by Region (2012-2017)
    3.2 United States Specialty Pharmaceutical Revenue and Market Share by Region (2012-2017)
    3.3 United States Specialty Pharmaceutical Price by Region (2012-2017)

4 United States Specialty Pharmaceutical Sales (Volume) and Revenue (Value) by Type (Product Category) (2012-2017)
    4.1 United States Specialty Pharmaceutical Sales and Market Share by Type (Product Category) (2012-2017)
    4.2 United States Specialty Pharmaceutical Revenue and Market Share by Type (2012-2017)
    4.3 United States Specialty Pharmaceutical Price by Type (2012-2017)
    4.4 United States Specialty Pharmaceutical Sales Growth Rate by Type (2012-2017)

5 United States Specialty Pharmaceutical Sales (Volume) by Application (2012-2017)
    5.1 United States Specialty Pharmaceutical Sales and Market Share by Application (2012-2017)
    5.2 United States Specialty Pharmaceutical Sales Growth Rate by Application (2012-2017)
    5.3 Market Drivers and Opportunities

6  United States Specialty Pharmaceutical Players/Suppliers Profiles and Sales Data
    6.1 Pfizer
        6.1.1 Company Basic Information, Manufacturing Base and Competitors
        6.1.2 Specialty Pharmaceutical Product Category, Application and Specification
            6.1.2.1 Product A
            6.1.2.2 Product B
        6.1.3 Pfizer Specialty Pharmaceutical Sales, Revenue, Price and Gross Margin (2012-2017)
        6.1.4 Main Business/Business Overview
    6.2 Roche
        6.2.2 Specialty Pharmaceutical Product Category, Application and Specification
            6.2.2.1 Product A
            6.2.2.2 Product B
        6.2.3 Roche Specialty Pharmaceutical Sales, Revenue, Price and Gross Margin (2012-2017)
        6.2.4 Main Business/Business Overview
    6.3 Amgen
        6.3.2 Specialty Pharmaceutical Product Category, Application and Specification
            6.3.2.1 Product A
            6.3.2.2 Product B
        6.3.3 Amgen Specialty Pharmaceutical Sales, Revenue, Price and Gross Margin (2012-2017)
        6.3.4 Main Business/Business Overview
    6.4 AbbVie
        6.4.2 Specialty Pharmaceutical Product Category, Application and Specification
            6.4.2.1 Product A
            6.4.2.2 Product B
        6.4.3 AbbVie Specialty Pharmaceutical Sales, Revenue, Price and Gross Margin (2012-2017)
        6.4.4 Main Business/Business Overview
    6.5 Novo Nordisk
        6.5.2 Specialty Pharmaceutical Product Category, Application and Specification
            6.5.2.1 Product A
            6.5.2.2 Product B
        6.5.3 Novo Nordisk Specialty Pharmaceutical Sales, Revenue, Price and Gross Margin (2012-2017)
        6.5.4 Main Business/Business Overview
    6.6 Johnson & Johnson
        6.6.2 Specialty Pharmaceutical Product Category, Application and Specification
            6.6.2.1 Product A
            6.6.2.2 Product B
        6.6.3 Johnson & Johnson Specialty Pharmaceutical Sales, Revenue, Price and Gross Margin (2012-2017)
        6.6.4 Main Business/Business Overview
    6.7 Sanofi-Aventis
        6.7.2 Specialty Pharmaceutical Product Category, Application and Specification
            6.7.2.1 Product A
            6.7.2.2 Product B
        6.7.3 Sanofi-Aventis Specialty Pharmaceutical Sales, Revenue, Price and Gross Margin (2012-2017)
        6.7.4 Main Business/Business Overview
    6.8 Merck
        6.8.2 Specialty Pharmaceutical Product Category, Application and Specification
            6.8.2.1 Product A
            6.8.2.2 Product B
        6.8.3 Merck Specialty Pharmaceutical Sales, Revenue, Price and Gross Margin (2012-2017)
        6.8.4 Main Business/Business Overview
    6.9 Eli Lilly
        6.9.2 Specialty Pharmaceutical Product Category, Application and Specification
            6.9.2.1 Product A
            6.9.2.2 Product B
        6.9.3 Eli Lilly Specialty Pharmaceutical Sales, Revenue, Price and Gross Margin (2012-2017)
        6.9.4 Main Business/Business Overview
    6.10 Novartis
        6.10.2 Specialty Pharmaceutical Product Category, Application and Specification
            6.10.2.1 Product A
            6.10.2.2 Product B
        6.10.3 Novartis Specialty Pharmaceutical Sales, Revenue, Price and Gross Margin (2012-2017)
        6.10.4 Main Business/Business Overview
    6.11 3sbio
    6.12 Changchun High Tech
    6.13 CP Guojian Pharmacy
    6.14 Biotech Pharma
    6.15 Gelgen Biopharma
    6.16 Innovent

7 Specialty Pharmaceutical Manufacturing Cost Analysis
    7.1 Specialty Pharmaceutical Key Raw Materials Analysis
        7.1.1 Key Raw Materials
        7.1.2 Price Trend of Key Raw Materials
        7.1.3 Key Suppliers of Raw Materials
        7.1.4 Market Concentration Rate of Raw Materials
    7.2 Proportion of Manufacturing Cost Structure
        7.2.1 Raw Materials
        7.2.2 Labor Cost
        7.2.3 Manufacturing Expenses
    7.3 Manufacturing Process Analysis of Specialty Pharmaceutical

8 Industrial Chain, Sourcing Strategy and Downstream Buyers
    8.1 Specialty Pharmaceutical Industrial Chain Analysis
    8.2 Upstream Raw Materials Sourcing
    8.3 Raw Materials Sources of Specialty Pharmaceutical Major Manufacturers in 2016
    8.4 Downstream Buyers

9 Marketing Strategy Analysis, Distributors/Traders
    9.1 Marketing Channel
        9.1.1 Direct Marketing
        9.1.2 Indirect Marketing
        9.1.3 Marketing Channel Development Trend
    9.2 Market Positioning
        9.2.1 Pricing Strategy
        9.2.2 Brand Strategy
        9.2.3 Target Client
    9.3 Distributors/Traders List

10 Market Effect Factors Analysis
    10.1 Technology Progress/Risk
        10.1.1 Substitutes Threat
        10.1.2 Technology Progress in Related Industry
    10.2 Consumer Needs/Customer Preference Change
    10.3 Economic/Political Environmental Change

11 United States Specialty Pharmaceutical Market Size (Value and Volume) Forecast (2017-2022)
    11.1 United States Specialty Pharmaceutical Sales Volume, Revenue Forecast (2017-2022)
    11.2 United States Specialty Pharmaceutical Sales Volume Forecast by Type (2017-2022)
    11.3 United States Specialty Pharmaceutical Sales Volume Forecast by Application (2017-2022)
    11.4 United States Specialty Pharmaceutical Sales Volume Forecast by Region (2017-2022)

12 Research Findings and Conclusion

13 Appendix
    13.1 Methodology/Research Approach
        13.1.1 Research Programs/Design
        13.1.2 Market Size Estimation
        13.1.3 Market Breakdown and Data Triangulation
    13.2 Data Source
        13.2.1 Secondary Sources
        13.2.2 Primary Sources
    13.3 Disclaimer



List of Tables and Figures 

    Figure Product Picture of Specialty Pharmaceutical
    Figure United States Specialty Pharmaceutical Market Size (K MT) by Type (2012-2022)
    Figure United States Specialty Pharmaceutical Sales Volume Market Share by Type (Product Category) in 2016
    Figure Antibody Product Picture
    Figure Hormone Product Picture
    Figure Growth Factors Product Picture
    Figure Other Product Picture
    Figure United States Specialty Pharmaceutical Market Size (K MT) by Application (2012-2022)
    Figure United States Sales Market Share of Specialty Pharmaceutical by Application in 2016
    Figure Tumor Examples
    Table Key Downstream Customer in Tumor
    Figure Diabetes Examples
    Table Key Downstream Customer in Diabetes
    Figure Cardiovascular Examples
    Table Key Downstream Customer in Cardiovascular
    Figure Hemophilia Examples
    Table Key Downstream Customer in Hemophilia
    Figure Other Examples
    Table Key Downstream Customer in Other
    Figure United States Specialty Pharmaceutical Market Size (Million USD) by Region (2012-2022)
    Figure The West Specialty Pharmaceutical Revenue (Million USD) and Growth Rate (2012-2022)
    Figure Southwest Specialty Pharmaceutical Revenue (Million USD) and Growth Rate (2012-2022)
    Figure The Middle Atlantic Specialty Pharmaceutical Revenue (Million USD) and Growth Rate (2012-2022)
    Figure New England Specialty Pharmaceutical Revenue (Million USD) and Growth Rate (2012-2022)
    Figure The South of US Specialty Pharmaceutical Revenue (Million USD) and Growth Rate (2012-2022)
    Figure The Midwest Specialty Pharmaceutical Revenue (Million USD) and Growth Rate (2012-2022)
    Figure United States Specialty Pharmaceutical Sales (K MT) and Growth Rate (2012-2022)
    Figure United States Specialty Pharmaceutical Revenue (Million USD) and Growth Rate (2012-2022)
    Figure United States Specialty Pharmaceutical Market Major Players Product Sales Volume (K MT) (2012-2017)
    Table United States Specialty Pharmaceutical Sales (K MT) of Key Players/Suppliers (2012-2017)
    Table United States Specialty Pharmaceutical Sales Share by Players/Suppliers (2012-2017)
    Figure 2016 United States Specialty Pharmaceutical Sales Share by Players/Suppliers
    Figure 2017 United States Specialty Pharmaceutical Sales Share by Players/Suppliers
    Figure United States Specialty Pharmaceutical Market Major Players Product Revenue (Million USD) (2012-2017)
    Table United States Specialty Pharmaceutical Revenue (Million USD) by Players/Suppliers (2012-2017)
    Table United States Specialty Pharmaceutical Revenue Share by Players/Suppliers (2012-2017)
    Figure 2016 United States Specialty Pharmaceutical Revenue Share by Players/Suppliers
    Figure 2017 United States Specialty Pharmaceutical Revenue Share by Players/Suppliers
    Table United States Market Specialty Pharmaceutical Average Price (USD/MT) of Key Players/Suppliers (2012-2017)
    Figure United States Market Specialty Pharmaceutical Average Price (USD/MT) of Key Players/Suppliers in 2016
    Figure United States Specialty Pharmaceutical Market Share of Top 3 Players/Suppliers
    Figure United States Specialty Pharmaceutical Market Share of Top 5 Players/Suppliers
    Table United States Players/Suppliers Specialty Pharmaceutical Manufacturing Base Distribution and Sales Area
    Table United States Players/Suppliers Specialty Pharmaceutical Product Category
    Table United States Specialty Pharmaceutical Sales (K MT) by Region (2012-2017)
    Table United States Specialty Pharmaceutical Sales Share by Region (2012-2017)
    Figure United States Specialty Pharmaceutical Sales Share by Region (2012-2017)
    Figure United States Specialty Pharmaceutical Sales Market Share by Region in 2016
    Table United States Specialty Pharmaceutical Revenue (Million USD) and Market Share by Region (2012-2017)
    Table United States Specialty Pharmaceutical Revenue Share by Region (2012-2017)
    Figure United States Specialty Pharmaceutical Revenue Market Share by Region (2012-2017)
    Figure United States Specialty Pharmaceutical Revenue Market Share by Region in 2016
    Table United States Specialty Pharmaceutical Price (USD/MT) by Region (2012-2017)
    Table United States Specialty Pharmaceutical Sales (K MT) by Type (2012-2017)
    Table United States Specialty Pharmaceutical Sales Share by Type (2012-2017)
    Figure United States Specialty Pharmaceutical Sales Share by Type (2012-2017)
    Figure United States Specialty Pharmaceutical Sales Market Share by Type in 2016
    Table United States Specialty Pharmaceutical Revenue  (Million USD) and Market Share by Type (2012-2017)
    Table United States Specialty Pharmaceutical Revenue Share by Type (2012-2017)
    Figure Revenue Market Share of Specialty Pharmaceutical by Type (2012-2017)
    Figure Revenue Market Share of Specialty Pharmaceutical by Type in 2016
    Table United States Specialty Pharmaceutical Price (USD/MT) by Types (2012-2017)
    Figure United States Specialty Pharmaceutical Sales Growth Rate by Type (2012-2017)
    Table United States Specialty Pharmaceutical Sales (K MT) by Application (2012-2017)
    Table United States Specialty Pharmaceutical Sales Market Share by Application (2012-2017)
    Figure United States Specialty Pharmaceutical Sales Market Share by Application (2012-2017)
    Figure United States Specialty Pharmaceutical Sales Market Share by Application in 2016
    Table United States Specialty Pharmaceutical Sales Growth Rate by Application (2012-2017)
    Figure United States Specialty Pharmaceutical Sales Growth Rate by Application (2012-2017)
    Table Pfizer Basic Information List
    Table Pfizer Specialty Pharmaceutical Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
    Figure Pfizer Specialty Pharmaceutical Sales Growth Rate (2012-2017)
    Figure Pfizer Specialty Pharmaceutical Sales Market Share in United States (2012-2017)
    Figure Pfizer Specialty Pharmaceutical Revenue Market Share in United States (2012-2017)
    Table Roche Basic Information List
    Table Roche Specialty Pharmaceutical Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
    Figure Roche Specialty Pharmaceutical Sales Growth Rate (2012-2017)
    Figure Roche Specialty Pharmaceutical Sales Market Share in United States (2012-2017)
    Figure Roche Specialty Pharmaceutical Revenue Market Share in United States (2012-2017)
    Table Amgen Basic Information List
    Table Amgen Specialty Pharmaceutical Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
    Figure Amgen Specialty Pharmaceutical Sales Growth Rate (2012-2017)
    Figure Amgen Specialty Pharmaceutical Sales Market Share in United States (2012-2017)
    Figure Amgen Specialty Pharmaceutical Revenue Market Share in United States (2012-2017)
    Table AbbVie Basic Information List
    Table AbbVie Specialty Pharmaceutical Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
    Figure AbbVie Specialty Pharmaceutical Sales Growth Rate (2012-2017)
    Figure AbbVie Specialty Pharmaceutical Sales Market Share in United States (2012-2017)
    Figure AbbVie Specialty Pharmaceutical Revenue Market Share in United States (2012-2017)
    Table Novo Nordisk Basic Information List
    Table Novo Nordisk Specialty Pharmaceutical Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
    Figure Novo Nordisk Specialty Pharmaceutical Sales Growth Rate (2012-2017)
    Figure Novo Nordisk Specialty Pharmaceutical Sales Market Share in United States (2012-2017)
    Figure Novo Nordisk Specialty Pharmaceutical Revenue Market Share in United States (2012-2017)
    Table Johnson & Johnson Basic Information List
    Table Johnson & Johnson Specialty Pharmaceutical Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
    Figure Johnson & Johnson Specialty Pharmaceutical Sales Growth Rate (2012-2017)
    Figure Johnson & Johnson Specialty Pharmaceutical Sales Market Share in United States (2012-2017)
    Figure Johnson & Johnson Specialty Pharmaceutical Revenue Market Share in United States (2012-2017)
    Table Sanofi-Aventis Basic Information List
    Table Sanofi-Aventis Specialty Pharmaceutical Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
    Figure Sanofi-Aventis Specialty Pharmaceutical Sales Growth Rate (2012-2017)
    Figure Sanofi-Aventis Specialty Pharmaceutical Sales Market Share in United States (2012-2017)
    Figure Sanofi-Aventis Specialty Pharmaceutical Revenue Market Share in United States (2012-2017)
    Table Merck Basic Information List
    Table Merck Specialty Pharmaceutical Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
    Figure Merck Specialty Pharmaceutical Sales Growth Rate (2012-2017)
    Figure Merck Specialty Pharmaceutical Sales Market Share in United States (2012-2017)
    Figure Merck Specialty Pharmaceutical Revenue Market Share in United States (2012-2017)
    Table Eli Lilly Basic Information List
    Table Eli Lilly Specialty Pharmaceutical Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
    Figure Eli Lilly Specialty Pharmaceutical Sales Growth Rate (2012-2017)
    Figure Eli Lilly Specialty Pharmaceutical Sales Market Share in United States (2012-2017)
    Figure Eli Lilly Specialty Pharmaceutical Revenue Market Share in United States (2012-2017)
    Table Novartis Basic Information List
    Table Novartis Specialty Pharmaceutical Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
    Figure Novartis Specialty Pharmaceutical Sales Growth Rate (2012-2017)
    Figure Novartis Specialty Pharmaceutical Sales Market Share in United States (2012-2017)
    Figure Novartis Specialty Pharmaceutical Revenue Market Share in United States (2012-2017)
    Table 3sbio Basic Information List
    Table Changchun High Tech Basic Information List
    Table CP Guojian Pharmacy Basic Information List
    Table Biotech Pharma Basic Information List
    Table Gelgen Biopharma Basic Information List
    Table Innovent Basic Information List
    Table Production Base and Market Concentration Rate of Raw Material
    Figure Price Trend of Key Raw Materials
    Table Key Suppliers of Raw Materials
    Figure Manufacturing Cost Structure of Specialty Pharmaceutical
    Figure Manufacturing Process Analysis of Specialty Pharmaceutical
    Figure Specialty Pharmaceutical Industrial Chain Analysis
    Table Raw Materials Sources of Specialty Pharmaceutical Major Players/Suppliers in 2016
    Table Major Buyers of Specialty Pharmaceutical
    Table Distributors/Traders List
    Figure United States Specialty Pharmaceutical Sales Volume (K MT) and Growth Rate Forecast (2017-2022)
    Figure United States Specialty Pharmaceutical Revenue  (Million USD) and Growth Rate Forecast (2017-2022)
    Figure United States Specialty Pharmaceutical Price (USD/MT) Trend Forecast (2017-2022)
    Table United States Specialty Pharmaceutical Sales Volume (K MT) Forecast by Type (2017-2022)
    Figure United States Specialty Pharmaceutical Sales Volume (K MT) Forecast by Type (2017-2022)
    Figure United States Specialty Pharmaceutical Sales Volume (K MT) Forecast by Type in 2022
    Table United States Specialty Pharmaceutical Sales Volume (K MT) Forecast by Application (2017-2022)
    Figure United States Specialty Pharmaceutical Sales Volume (K MT) Forecast by Application (2017-2022)
    Figure United States Specialty Pharmaceutical Sales Volume (K MT) Forecast by Application in 2022
    Table United States Specialty Pharmaceutical Sales Volume (K MT) Forecast by Region (2017-2022)
    Table United States Specialty Pharmaceutical Sales Volume Share Forecast by Region (2017-2022)
    Figure United States Specialty Pharmaceutical Sales Volume Share Forecast by Region (2017-2022)
    Figure United States Specialty Pharmaceutical Sales Volume Share Forecast by Region in 2022
    Table Research Programs/Design for This Report
    Figure Bottom-up and Top-down Approaches for This Report
    Figure Data Triangulation
    Table Key Data Information from Secondary Sources
    Table Key Data Information from Primary Sources


Let our analyst help you with a customized solution for your market research needs

Select the license

Credit card Logo
hkjkhjkhjkhjkmjhjhkhjkjkhjkhjkm
Discount  Check Discount Question  Any Questions
hkjkhjkhjkhjkmjhjhkhjkjkhjkhjkm
fgfhfhfgf